CXCL12 and neoplasm: The results showed that exogenous and autocrine IL-1α could significantly increase the secretion of CXCL12 by the important stromal fibroblasts in tumor microenvironment, which could be inhibited by interleukin 1 receptor antagonist (IL-1Ra).